These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15842374)

  • 1. Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations.
    O'Brien LA; Sutherland JJ; Weaver DF; Lillicrap D
    J Thromb Haemost; 2005 Apr; 3(4):796-7. PubMed ID: 15842374
    [No Abstract]   [Full Text] [Related]  

  • 2. The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.
    Ribba AN; Hilbert L; Lavergne JM; Fressinaud E; Boyer-Neumann C; Ternisien C; Juhan-Vague I; Goudemand J; Girma J; Mazurier C; Meyer D
    Blood; 2001 Feb; 97(4):952-9. PubMed ID: 11159522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations.
    Sutherland JJ; O'Brien LA; Lillicrap D; Weaver DF
    J Mol Model; 2004 Aug; 10(4):259-70. PubMed ID: 15322948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional modelling of von Willebrand factor type A domains in complement and coagulation.
    Perkins SJ; Hinshelwood J; Edwards YJ; Jenkins PV
    Biochem Soc Trans; 1999 Dec; 27(6):815-20. PubMed ID: 10830108
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Ivaskevicius V; Klamroth R; Oldenburg J
    Haematologica; 2013 Aug; 98(8):1315-23. PubMed ID: 23539537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene.
    Hilbert L; D'Oiron R; Fressinaud E; Meyer D; Mazurier C;
    J Thromb Haemost; 2004 Dec; 2(12):2271-3. PubMed ID: 15613050
    [No Abstract]   [Full Text] [Related]  

  • 7. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E; Mazurier C; Meyer D
    Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
    Jenkins PV; Pasi KJ; Perkins SJ
    Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Arg834Gln and Val902Glu type 2A von Willebrand disease mutations: studies with recombinant von Willebrand factor and correlation with patient characteristics.
    Englender T; Lattuada A; Mannucci PM; Sadler JE; Inbal A
    Blood; 1996 Apr; 87(7):2788-94. PubMed ID: 8639896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.
    Wang JW; Groeneveld DJ; Cosemans G; Dirven RJ; Valentijn KM; Voorberg J; Reitsma PH; Eikenboom J
    Haematologica; 2012 Jun; 97(6):859-66. PubMed ID: 22207689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.
    Millar CM; Riddel AF; Griffioe A; Jenkin PV; Brown SA
    Br J Haematol; 2005 Aug; 130(3):462-3. PubMed ID: 16042701
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
    Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
    Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease.
    Enayat MS; Guilliatt AM; Surdhar GK; Jenkins PV; Pasi KJ; Toh CH; Williams MD; Hill FG
    Blood; 2001 Aug; 98(3):674-80. PubMed ID: 11468166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
    Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
    J Thromb Haemost; 2006 Sep; 4(9):2088-90. PubMed ID: 16961623
    [No Abstract]   [Full Text] [Related]  

  • 19. Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation.
    Castaman G; Eikenboom JC; Lattuada A; Mannucci PM; Rodeghiero F
    Br J Haematol; 2000 Jan; 108(1):188-90. PubMed ID: 10651743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.